Dr Kerstin Papenfuss, Deep Science Ventures, and Ben Holland, Antiverse, discuss how generative AI is helping advance antibody discovery. The therapeutic antibody, once 'the next big thing,' has matured into a cornerstone of modern medicine, standing alongside small molecules as a staple of drug development. Yet, while artificial intelligence (AI) has dramatically accelerated small molecule discovery, the […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!